Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Galiximab Recombinant Human Monoclonal Antibody (IDEC-114 (Galiximab))
GREENER_CHOICE

Catalog No. PIMA548059
Change view
Click to view available options
Quantity:
200 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIMA548059 200 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PIMA548059 Supplier Invitrogen™ Supplier No. MA548059
Add to Cart
Add to Cart

Human Recombinant Monoclonal Antibody

Specificity: Galiximab is a primatized mAb which consists of human constant and primate (cynomolgus macaque) variable regions and binds specifically to CD80.

Galiximab is a chimeric monoclonal antibody which is used as an immunosuppressive pharmaceutical.
TRUSTED_SUSTAINABILITY

Specifications

Antigen Galiximab
Applications ELISA, Flow Cytometry, Inhibition Assays, Immunohistochemistry, Immunoprecipitation, Western Blot
Classification Recombinant Monoclonal
Clone IDEC-114 (Galiximab)
Concentration 1 mg/mL
Conjugate Unconjugated
Formulation PBS with 0.02% ProClin 300
Gene INSR
Gene Accession No. P06213
Gene Alias IDEC-114
Host Species Human
Immunogen Galiximab was prepared by immunizing cynomolgus monkeys with recombinant CD80 antigen.
Purification Method Protein A
Quantity 200 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 3643
Target Species Human
Content And Storage Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Product Type Antibody
Form Liquid
Isotype IgG1 λ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.